In this issue:
Haemodynamic-guided management of HF
Cost-effectiveness of dapagliflozin in HFREF
Dapagliflozin’s effects on ventricular arrhythmias, resuscitated cardiac arrest and sudden death
Performance of H2FPEF and HFA-PEFF for HFPEF diagnosis
CCM in ischaemic vs. nonischaemic cardiomyopathy
Empagliflozin improves CV/renal outcomes in HF regardless of systolic BP
2021 ESC guidelines for diagnosing and treating acute and chronic HF
Longitudinal outcomes associated with non-evidence-based ICDs
Rehabilitation for older patients with acute HFPEF vs. HFREF
Lung ultrasound-guided ED management of acute HF
Please login below to download this issue (PDF)